Register for email alerts and news feeds:
This journal | BMJ Group
rss
Drug and Therapeutics Bulletin 1998;36:73-76; doi:10.1136/dtb.1998.361073
Copyright © 1998 by the BMJ Publishing Group Ltd.

The place of pneumococcal vaccination

Relevant BNF section: 14.4

Vaccination against pneumococcal infection was introduced in the UK in 1979. Currently, the vaccine is recommended by the Department of Health for patients at high risk of developing pneumococcal infection.1 Here we discuss the epidemiology of pneumococcal infection and consider the effectiveness of the vaccines available and their use in clinical practice.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Pistelli, R., Lange, P., Miller, D.L. (2003). Determinants of prognosis of COPD in the elderly: mucus hypersecretion, infections, cardiovascular comorbidity. Eur Respir J 21: 10S-14s [Abstract] [Full Text]  
  • Soh, S. W.-L., Poh, C. L., Lin, R. V. T. P. (2000). Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Isolates from Pediatric Patients in Singapore. Antimicrob. Agents Chemother. 44: 2193-2196 [Abstract] [Full Text]